Literature DB >> 10671791

Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases.

V Serretta1, G Pomara, F Piazza, E Gange.   

Abstract

INTRODUCTION: Pure squamous carcinoma (SCC) is a rare entity in western regions. The management of SCC still remains similar to that of transitional carcinoma, although it is a different entity. A retrospective review can be helpful in understanding the biological behavior of this uncommon vesical tumour.
MATERIAL AND METHODS: Nineteen consecutive cases of pure SCC of the bladder, not related to bilharziasis or spinal cord injury, are herein reported. Fifteen patients were submitted to radical cystectomy, combined with emasculation in 1 case and unilateral nephroureterectomy in another. Partial cystectomy was performed in 1 patient and transurethral resection followed by radiotherapy in 3 more cases. Involvement of prostatic urethra and upper urinary tract was evident in 9 (47.3%) and 5 patients (26.3%), respectively. Four patients were submitted to neoadjuvant chemotherapy and 1 to presurgical radiotherapy without any objective response. Adjuvant chemotherapy was performed in 3 patients. At a mean follow-up of 52 months, 6 patients (31.5%) are alive without any evidence of disease. SCC antigen was monitored in 5 patients. The possible role of this marker in bladder SCC is discussed.
CONCLUSIONS: Invasion of the upper urinary tract and prostatic urethra seems more common in SCC than in transitional cell carcinoma. Distant metastases are rare. Most patients die after attempts of locoregional control of the tumor have failed. Extensive surgery is recommended. Preoperative radiotherapy should be considered since pelvic recurrences are the leading cause of progression in squamous cell carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10671791     DOI: 10.1159/000020105

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

1.  Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine.

Authors:  Kazuyoshi Shigehara; Yasuhide Kitagawa; Takao Nakashima; Masayoshi Shimamura
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 2.  Chemotherapy for bladder cancer in patients with impaired renal function.

Authors:  Steve Nicholson
Journal:  Nat Rev Urol       Date:  2011-11-22       Impact factor: 14.432

3.  Squamous cell carcinoma in exstrophy of the bladder.

Authors:  Pramod Kumar Sharma; Praveen Kumar Pandey; Mukesh Kumar Vijay; Malay Kumar Bera; Jitendra Pratap Singh; Kaushik Saha
Journal:  Korean J Urol       Date:  2013-08-07

4.  Bladder Stones Associated with an Aggressive Plasmacytoid Variant of Urothelial Cancer: A Rare Case and Literature Review.

Authors:  Mohammed Alsheikh; Mohammad Faruquz Zaman; Preethi Gopinath; Ahmed Qteishat
Journal:  Curr Urol       Date:  2020-01-07

5.  Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.

Authors:  Aaron Dotson; Allison May; Facundo Davaro; Syed Johar Raza; Sameer Siddiqui; Zachary Hamilton
Journal:  Int J Clin Oncol       Date:  2019-02-01       Impact factor: 3.402

6.  Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract.

Authors:  Jung Yong Hong; Moon Ki Choi; Ji Eun Uhm; Min Jae Park; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Won Seog Kim; Won Ki Kang; Hyun Moo Lee; Han Yong Choi; Hoyeong Lim
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

7.  Primary squamous cell carcinoma of the urinary bladder presenting as peritoneal carcinomatosis.

Authors:  Himisha Beltran; Brian D Robinson; Scott T Tagawa
Journal:  Adv Urol       Date:  2010-06-27

Review 8.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

9.  Establishment and characterization of a new squamous cell carcinoma cell line, TMUU-08, derived from human bladder cancer.

Authors:  Choichiro Ozu; Hisashi Takeuchi; Kazuhito Matsushita; Yutaka Horiguchi; Kazunori Namiki; Kunihiko Yoshioka; Takeshi Nagai; Masaaki Tachibana
Journal:  Hum Cell       Date:  2009-02       Impact factor: 4.174

10.  Intermittent self-catheterization and the risk of squamous cell cancer of the bladder: An emerging clinical entity?

Authors:  Rowan G Casey; Ivor M Cullen; Tom Crotty; David M Quinlan
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.